Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice that warned about potential delays in updates due to government funding; this is an administrative update and does not change the study details.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding status notice to the page and updated the version from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThese are minor front-end and metadata updates (glossary toggle, QC-related labels, and version information) with the removal of outdated labels, which do not affect core study content or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a new Locations section with California as a site and updated the revision to v3.3.3. Removed the prior California Locations entry and the HHS Vulnerability Disclosure section, replacing the previous revision (v3.3.2) with v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page revision metadata was updated (Revision: v3.3.2 added; Revision: v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.